These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36808355)
1. Effect of proton pump inhibitors on Magnesium levels in Type II diabetic patients: a single centre study from Saudi Arabia. Lateef Junaid MA; Faraz A; Vaseem M; Salih IMA; Kutbi HAH; Al Julifi MZ; Alfhaid FM; Sami W Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):1077-1082. PubMed ID: 36808355 [TBL] [Abstract][Full Text] [Related]
2. The Prevalence of Hypomagnesemia in Hospitalized Type 2 Diabetic Patients Treated with Diuretics and/or Proton Pump Inhibitors. Mengesha B; Levi D; Kroonenberg M; Koren R; Golik A; Koren S Isr Med Assoc J; 2021 Apr; 23(4):245-250. PubMed ID: 33899358 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients. Recart DA; Ferraris A; Petriglieri CI; Alonso Serena M; Bonella MB; Posadas-Martinez ML Intern Emerg Med; 2021 Apr; 16(3):711-717. PubMed ID: 33001349 [TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study. Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862 [TBL] [Abstract][Full Text] [Related]
5. Is there a correlation between hypomagnesemia linked to long-term proton pump inhibitor use and the active agent? Aydın Yoldemir Ş; Zeren Ozturk G; Akarsu M; Ozcan M Wien Klin Wochenschr; 2022 Feb; 134(3-4):104-109. PubMed ID: 33751184 [TBL] [Abstract][Full Text] [Related]
7. The association of proton pump inhibitors and hypomagnesemia in the community setting. Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616 [TBL] [Abstract][Full Text] [Related]
8. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. Park CH; Kim EH; Roh YH; Kim HY; Lee SK PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217 [TBL] [Abstract][Full Text] [Related]
9. Uses of proton pump inhibitors and hypomagnesemia. Gau JT; Yang YX; Chen R; Kao TC Pharmacoepidemiol Drug Saf; 2012 May; 21(5):553-9. PubMed ID: 22337212 [TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use. Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412 [TBL] [Abstract][Full Text] [Related]
11. Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users. Biyik M; Solak Y; Ucar R; Cifci S; Tekis D; Polat İ; Göktepe MH; Sakiz D; Ataseven H; Demir A Am J Ther; 2017; 24(1):e52-e55. PubMed ID: 25353358 [TBL] [Abstract][Full Text] [Related]
12. Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia. Kim S; Lee H; Park CH; Shim CN; Lee HJ; Park JC; Shin SK; Lee SK; Lee YC; Kim HY; Kang DR Am J Ther; 2015; 22(1):14-21. PubMed ID: 23846522 [TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia. Boerlage TC; van Hees CL; Huitema AD; Lauw FN Obes Surg; 2016 Mar; 26(3):688-90. PubMed ID: 26762281 [TBL] [Abstract][Full Text] [Related]
14. Proton Pump Inhibitors and Hypomagnesemia in Older Inpatients: An Observational Study. Anna Vermeulen Windsant-van den Tweel AM; Derijks HJ; Gadiot NPPM; Keijsers CJPW Sr Care Pharm; 2022 Dec; 37(12):623-630. PubMed ID: 36461136 [No Abstract] [Full Text] [Related]
15. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study. Ago R; Shindo T; Banshodani M; Shintaku S; Moriishi M; Masaki T; Kawanishi H Hemodial Int; 2016 Oct; 20(4):580-588. PubMed ID: 27329549 [TBL] [Abstract][Full Text] [Related]
16. Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study. Nakashima A; Ohkido I; Yokoyama K; Mafune A; Urashima M; Yokoo T PLoS One; 2015; 10(11):e0143656. PubMed ID: 26618538 [TBL] [Abstract][Full Text] [Related]
17. Proton-pump inhibitor use is associated with low serum magnesium concentrations. Danziger J; William JH; Scott DJ; Lee J; Lehman LW; Mark RG; Howell MD; Celi LA; Mukamal KJ Kidney Int; 2013 Apr; 83(4):692-9. PubMed ID: 23325090 [TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study. Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254 [TBL] [Abstract][Full Text] [Related]
19. Serum magnesium and proton-pump inhibitors use: a cross-sectional study. Faulhaber GA; Ascoli BM; Lubini A; Mossmann M; Rossi G; Geib G; Furlanetto TW Rev Assoc Med Bras (1992); 2013; 59(3):276-9. PubMed ID: 23680271 [TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us? Luk CP; Parsons R; Lee YP; Hughes JD Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]